Squamous Cell Carcinoma of the Oral Cavity Clinical Trials

25 clinical trials for Squamous Cell Carcinoma of the Oral Cavity across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck — RECRUITING · PHASE2
• Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer — RECRUITING · PHASE2
• Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome — RECRUITING
• Psychological attachment styles and post-treatment outcomes following therapy for oral squamous cell carcinoma: a multicenter observational study — NOT_YET_RECRUITING
• Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma — COMPLETED · PHASE1
• Contribution of Residual Tumour DNA Testing on the Surgical Bed — ACTIVE_NOT_RECRUITING · NA
• Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC — WITHDRAWN · PHASE2
• Antitumor-B KAC PK Study — WITHDRAWN · PHASE1
• CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer — COMPLETED · PHASE2
• Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer — COMPLETED · PHASE1
• CHG0521 Oral Coating in Patients with Solid Tissue Tumor/Recurrent/Metastatic TSCC — NOT_YET_RECRUITING · NA
• IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity — COMPLETED · PHASE2
• Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study — COMPLETED · PHASE1
• Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity — COMPLETED · PHASE3
• Phase 2 Trial of Maintenance Cemiplimab for Head and Neck Squamous Cell Carcinoma (HNSCC) — WITHDRAWN · PHASE2
• Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity — COMPLETED · NA
• Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity — COMPLETED · PHASE2
• Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients — OTHER · NA
• Recurrence in Buccinator Muscle Excision With the Skin Versus Without the Skin in Buccal Squamous Cell Carcinoma — OTHER · NA
• Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity — TERMINATED · PHASE1
• A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck — COMPLETED · PHASE1
• TPF-Induction Chemotherapy of Oropharyngeal and Cavity of the Mouth Cancer — COMPLETED · PHASE1
• Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium — COMPLETED
• A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis — TERMINATED

Refine this search